These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 12748215

  • 1. Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.
    Bollano E, Täng MS, Hjalmarson A, Waagstein F, Andersson B.
    Heart; 2003 Jun; 89(6):621-4. PubMed ID: 12748215
    [Abstract] [Full Text] [Related]

  • 2. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L.
    J Am Coll Cardiol; 2002 Oct 02; 40(7):1248-58. PubMed ID: 12383572
    [Abstract] [Full Text] [Related]

  • 3. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
    Maack C, Elter T, Nickenig G, LaRosee K, Crivaro M, Stäblein A, Wuttke H, Böhm M.
    J Am Coll Cardiol; 2001 Oct 02; 38(4):939-46. PubMed ID: 11583862
    [Abstract] [Full Text] [Related]

  • 4. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 5. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
    Sanderson JE, Chan SK, Yip G, Yeung LY, Chan KW, Raymond K, Woo KS.
    J Am Coll Cardiol; 1999 Nov 01; 34(5):1522-8. PubMed ID: 10551702
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol.
    Triposkiadis F, Dalampiras P, Kelepeshis G, Skoularigis J, Sitafidis G.
    Int J Clin Pharmacol Ther; 2008 Mar 01; 46(3):136-9. PubMed ID: 18397684
    [Abstract] [Full Text] [Related]

  • 7. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C.
    Vasc Health Risk Manag; 2007 Mar 01; 3(1):31-7. PubMed ID: 17583173
    [Abstract] [Full Text] [Related]

  • 8. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A, COMET Investigators.
    Am Heart J; 2005 Feb 01; 149(2):370-6. PubMed ID: 15846279
    [Abstract] [Full Text] [Related]

  • 9. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
    Arslan S, Erol MK, Bozkurt E, Acikel M, Gundogdu F, Atesal S, Senocak H.
    Int J Cardiovasc Imaging; 2007 Oct 01; 23(5):549-55. PubMed ID: 17171429
    [Abstract] [Full Text] [Related]

  • 10. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
    Lindenfeld J, Lowes BD, Bristow MR.
    Ann Pharmacother; 1999 Dec 01; 33(12):1266-9. PubMed ID: 10630826
    [Abstract] [Full Text] [Related]

  • 11. Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol.
    Maack C, Elter T, Böhm M.
    Congest Heart Fail; 2003 Dec 01; 9(5):263-70. PubMed ID: 14564145
    [Abstract] [Full Text] [Related]

  • 12. Effect of carvedilol versus metoprolol CR/XL on mortality in patients with heart failure treated with cardiac resynchronization therapy: a COX multivariate regression analysis.
    Shen X, Nair CK, Aronow WS, Hee T, Esterbrooks DJ.
    Am J Ther; 2013 Dec 01; 20(3):247-53. PubMed ID: 21642836
    [Abstract] [Full Text] [Related]

  • 13. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
    Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A, Carvedilol Or Metoprolol European Trial Investigators.
    Lancet; 2003 Jul 05; 362(9377):7-13. PubMed ID: 12853193
    [Abstract] [Full Text] [Related]

  • 14. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS, Munger M, Macgregor J, Lombardi WL, Stoddard GP, Gilbert EM.
    Pharmacotherapy; 2009 Aug 05; 29(8):883-90. PubMed ID: 19637941
    [Abstract] [Full Text] [Related]

  • 15. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure.
    Kukin ML, Kalman J, Charney RH, Levy DK, Buchholz-Varley C, Ocampo ON, Eng C.
    Circulation; 1999 May 25; 99(20):2645-51. PubMed ID: 10338457
    [Abstract] [Full Text] [Related]

  • 16. Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial.
    Packer M.
    J Card Fail; 2003 Dec 25; 9(6):429-43. PubMed ID: 14966782
    [Abstract] [Full Text] [Related]

  • 17. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H, Turk U, Ozdogan O, Akyuz S, Kirilmaz B, Alioglu E, Gunduz R, Bozkaya YT, Turkoglu C, Payzin S.
    Cardiovasc Ther; 2008 Dec 25; 26(3):182-8. PubMed ID: 18786088
    [Abstract] [Full Text] [Related]

  • 18. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA, COMET investors.
    Eur J Heart Fail; 2005 Jun 25; 7(4):640-9. PubMed ID: 15921806
    [Abstract] [Full Text] [Related]

  • 19. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD.
    Eur J Heart Fail; 2005 Jun 25; 7(4):618-23. PubMed ID: 15921803
    [Abstract] [Full Text] [Related]

  • 20. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
    Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR.
    Int J Cardiol; 2001 Dec 25; 81(2-3):141-9. PubMed ID: 11744130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.